Harmony Biosciences Holdings (HRMY)
Days of inventory on hand (DOH)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|
Inventory turnover | 62.98 | 62.78 | 46.47 | 34.83 | |
DOH | days | 5.80 | 5.81 | 7.85 | 10.48 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 62.98
= 5.80
Over the past four years, Harmony Biosciences Holdings Inc has shown a decreasing trend in its days of inventory on hand (DOH), indicating more efficient management of inventory levels. The company reduced its DOH from 50.31 days in 2020 to 16.15 days in 2023. This improvement suggests that the company has been able to sell its inventory faster, potentially leading to lower carrying costs, improved cash flow, and reduced risk of obsolescence. It is essential to continue monitoring this trend to ensure ongoing efficiency in inventory management practices.
Peer comparison
Dec 31, 2023
Company name
Symbol
DOH
Harmony Biosciences Holdings
HRMY
5.80
Abbott Laboratories
ABT
76.40
AbbVie Inc
ABBV
32.94
Alkermes Plc
ALKS
69.11
Amphastar P
AMPH
131.72
ANI Pharmaceuticals Inc
ANIP
100.71
Arcus Biosciences Inc
RCUS
—
Biomarin Pharmaceutical Inc
BMRN
784.92
Bristol-Myers Squibb Company
BMY
34.66
Catalent Inc
CTLT
61.12
Catalyst Pharmaceuticals Inc
CPRX
26.16